nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP2C19—prostate cancer	0.214	0.611	CbGaD
Esomeprazole—CYP3A4—prostate cancer	0.136	0.389	CbGaD
Esomeprazole—CYP2C19—Bicalutamide—prostate cancer	0.0493	0.126	CbGbCtD
Esomeprazole—CYP2C19—Nilutamide—prostate cancer	0.0493	0.126	CbGbCtD
Esomeprazole—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0453	0.116	CbGbCtD
Esomeprazole—CYP2C19—Flutamide—prostate cancer	0.0408	0.105	CbGbCtD
Esomeprazole—CYP3A4—Bicalutamide—prostate cancer	0.0238	0.061	CbGbCtD
Esomeprazole—CYP3A4—Estramustine—prostate cancer	0.0221	0.0567	CbGbCtD
Esomeprazole—CYP3A4—Abiraterone—prostate cancer	0.0197	0.0506	CbGbCtD
Esomeprazole—CYP3A4—Flutamide—prostate cancer	0.0197	0.0506	CbGbCtD
Esomeprazole—CYP2C19—Estradiol—prostate cancer	0.017	0.0434	CbGbCtD
Esomeprazole—CYP3A4—Cabazitaxel—prostate cancer	0.0146	0.0374	CbGbCtD
Esomeprazole—CYP2C19—Prednisone—prostate cancer	0.0146	0.0374	CbGbCtD
Esomeprazole—CYP3A4—Estrone—prostate cancer	0.0143	0.0366	CbGbCtD
Esomeprazole—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0127	0.0326	CbGbCtD
Esomeprazole—CYP3A4—Conjugated Estrogens—prostate cancer	0.00934	0.0239	CbGbCtD
Esomeprazole—CYP3A4—Mitoxantrone—prostate cancer	0.00849	0.0217	CbGbCtD
Esomeprazole—CYP3A4—Estradiol—prostate cancer	0.0082	0.021	CbGbCtD
Esomeprazole—CYP3A4—Prednisone—prostate cancer	0.00705	0.0181	CbGbCtD
Esomeprazole—CYP3A4—Etoposide—prostate cancer	0.00535	0.0137	CbGbCtD
Esomeprazole—CYP3A4—Docetaxel—prostate cancer	0.0049	0.0125	CbGbCtD
Esomeprazole—CYP3A4—Doxorubicin—prostate cancer	0.00365	0.00935	CbGbCtD
Esomeprazole—CYP2C19—urine—prostate cancer	0.000802	0.274	CbGeAlD
Esomeprazole—ATP4A—epithelium—prostate cancer	0.000605	0.207	CbGeAlD
Esomeprazole—Omeprazole—CYP2C18—prostate cancer	0.000565	0.123	CrCbGaD
Esomeprazole—ATP4A—renal system—prostate cancer	0.000562	0.192	CbGeAlD
Esomeprazole—Lansoprazole—CYP2C18—prostate cancer	0.000517	0.113	CrCbGaD
Esomeprazole—CYP3A4—urine—prostate cancer	0.000474	0.162	CbGeAlD
Esomeprazole—Omeprazole—CYP1B1—prostate cancer	0.000467	0.102	CrCbGaD
Esomeprazole—Lansoprazole—CYP1B1—prostate cancer	0.000427	0.0933	CrCbGaD
Esomeprazole—ATP4A—testis—prostate cancer	0.000363	0.124	CbGeAlD
Esomeprazole—Rabeprazole—CYP2C19—prostate cancer	0.000311	0.0679	CrCbGaD
Esomeprazole—Pantoprazole—CYP2C19—prostate cancer	0.000311	0.0679	CrCbGaD
Esomeprazole—Rabeprazole—CYP1A1—prostate cancer	0.000309	0.0676	CrCbGaD
Esomeprazole—Omeprazole—CYP2C19—prostate cancer	0.000253	0.0553	CrCbGaD
Esomeprazole—Omeprazole—CYP1A1—prostate cancer	0.000252	0.0551	CrCbGaD
Esomeprazole—Lansoprazole—CYP2C19—prostate cancer	0.000232	0.0506	CrCbGaD
Esomeprazole—Lansoprazole—CYP1A1—prostate cancer	0.000231	0.0504	CrCbGaD
Esomeprazole—Pantoprazole—CYP3A4—prostate cancer	0.000198	0.0431	CrCbGaD
Esomeprazole—Rabeprazole—CYP3A4—prostate cancer	0.000198	0.0431	CrCbGaD
Esomeprazole—Omeprazole—CYP3A4—prostate cancer	0.000161	0.0352	CrCbGaD
Esomeprazole—Lansoprazole—CYP3A4—prostate cancer	0.000147	0.0322	CrCbGaD
Esomeprazole—CYP3A4—renal system—prostate cancer	0.000116	0.0397	CbGeAlD
Esomeprazole—Visual impairment—Epirubicin—prostate cancer	3.15e-05	0.000151	CcSEcCtD
Esomeprazole—Agranulocytosis—Doxorubicin—prostate cancer	3.14e-05	0.000151	CcSEcCtD
Esomeprazole—Hypertension—Prednisone—prostate cancer	3.14e-05	0.00015	CcSEcCtD
Esomeprazole—Rash—Mitoxantrone—prostate cancer	3.14e-05	0.00015	CcSEcCtD
Esomeprazole—Dermatitis—Mitoxantrone—prostate cancer	3.13e-05	0.00015	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.13e-05	0.00015	CcSEcCtD
Esomeprazole—Headache—Mitoxantrone—prostate cancer	3.12e-05	0.000149	CcSEcCtD
Esomeprazole—Insomnia—Docetaxel—prostate cancer	3.11e-05	0.000149	CcSEcCtD
Esomeprazole—Myalgia—Prednisone—prostate cancer	3.09e-05	0.000148	CcSEcCtD
Esomeprazole—Arthralgia—Prednisone—prostate cancer	3.09e-05	0.000148	CcSEcCtD
Esomeprazole—Paraesthesia—Docetaxel—prostate cancer	3.09e-05	0.000148	CcSEcCtD
Esomeprazole—Erythema multiforme—Epirubicin—prostate cancer	3.09e-05	0.000148	CcSEcCtD
Esomeprazole—Anxiety—Prednisone—prostate cancer	3.08e-05	0.000148	CcSEcCtD
Esomeprazole—Bradycardia—Doxorubicin—prostate cancer	3.08e-05	0.000147	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.07e-05	0.000147	CcSEcCtD
Esomeprazole—Dyspnoea—Docetaxel—prostate cancer	3.07e-05	0.000147	CcSEcCtD
Esomeprazole—Somnolence—Docetaxel—prostate cancer	3.06e-05	0.000147	CcSEcCtD
Esomeprazole—Discomfort—Prednisone—prostate cancer	3.06e-05	0.000146	CcSEcCtD
Esomeprazole—Eye disorder—Epirubicin—prostate cancer	3.05e-05	0.000146	CcSEcCtD
Esomeprazole—Hypersensitivity—Etoposide—prostate cancer	3.05e-05	0.000146	CcSEcCtD
Esomeprazole—Tinnitus—Epirubicin—prostate cancer	3.04e-05	0.000146	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.03e-05	0.000145	CcSEcCtD
Esomeprazole—Flushing—Epirubicin—prostate cancer	3.03e-05	0.000145	CcSEcCtD
Esomeprazole—Rhinitis—Doxorubicin—prostate cancer	3.03e-05	0.000145	CcSEcCtD
Esomeprazole—Dyspepsia—Docetaxel—prostate cancer	3.03e-05	0.000145	CcSEcCtD
Esomeprazole—Hepatitis—Doxorubicin—prostate cancer	3.02e-05	0.000145	CcSEcCtD
Esomeprazole—Insomnia—Capecitabine—prostate cancer	3.01e-05	0.000144	CcSEcCtD
Esomeprazole—Hypoaesthesia—Doxorubicin—prostate cancer	3.01e-05	0.000144	CcSEcCtD
Esomeprazole—Pharyngitis—Doxorubicin—prostate cancer	3e-05	0.000144	CcSEcCtD
Esomeprazole—Paraesthesia—Capecitabine—prostate cancer	2.99e-05	0.000143	CcSEcCtD
Esomeprazole—Decreased appetite—Docetaxel—prostate cancer	2.99e-05	0.000143	CcSEcCtD
Esomeprazole—Urinary tract disorder—Doxorubicin—prostate cancer	2.98e-05	0.000143	CcSEcCtD
Esomeprazole—Oedema peripheral—Doxorubicin—prostate cancer	2.98e-05	0.000143	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Docetaxel—prostate cancer	2.97e-05	0.000142	CcSEcCtD
Esomeprazole—Asthenia—Etoposide—prostate cancer	2.97e-05	0.000142	CcSEcCtD
Esomeprazole—Connective tissue disorder—Doxorubicin—prostate cancer	2.97e-05	0.000142	CcSEcCtD
Esomeprazole—Dyspnoea—Capecitabine—prostate cancer	2.97e-05	0.000142	CcSEcCtD
Esomeprazole—Anaphylactic shock—Prednisone—prostate cancer	2.97e-05	0.000142	CcSEcCtD
Esomeprazole—Fatigue—Docetaxel—prostate cancer	2.97e-05	0.000142	CcSEcCtD
Esomeprazole—Urethral disorder—Doxorubicin—prostate cancer	2.96e-05	0.000142	CcSEcCtD
Esomeprazole—Nausea—Mitoxantrone—prostate cancer	2.96e-05	0.000142	CcSEcCtD
Esomeprazole—Immune system disorder—Epirubicin—prostate cancer	2.95e-05	0.000141	CcSEcCtD
Esomeprazole—Infection—Prednisone—prostate cancer	2.95e-05	0.000141	CcSEcCtD
Esomeprazole—Mediastinal disorder—Epirubicin—prostate cancer	2.94e-05	0.000141	CcSEcCtD
Esomeprazole—Constipation—Docetaxel—prostate cancer	2.94e-05	0.000141	CcSEcCtD
Esomeprazole—Pain—Docetaxel—prostate cancer	2.94e-05	0.000141	CcSEcCtD
Esomeprazole—Dyspepsia—Capecitabine—prostate cancer	2.93e-05	0.00014	CcSEcCtD
Esomeprazole—Chills—Epirubicin—prostate cancer	2.93e-05	0.00014	CcSEcCtD
Esomeprazole—Pruritus—Etoposide—prostate cancer	2.93e-05	0.00014	CcSEcCtD
Esomeprazole—Shock—Prednisone—prostate cancer	2.92e-05	0.00014	CcSEcCtD
Esomeprazole—Visual impairment—Doxorubicin—prostate cancer	2.91e-05	0.00014	CcSEcCtD
Esomeprazole—Nervous system disorder—Prednisone—prostate cancer	2.91e-05	0.000139	CcSEcCtD
Esomeprazole—Tachycardia—Prednisone—prostate cancer	2.89e-05	0.000139	CcSEcCtD
Esomeprazole—Decreased appetite—Capecitabine—prostate cancer	2.89e-05	0.000139	CcSEcCtD
Esomeprazole—Alopecia—Epirubicin—prostate cancer	2.89e-05	0.000138	CcSEcCtD
Esomeprazole—Skin disorder—Prednisone—prostate cancer	2.88e-05	0.000138	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Capecitabine—prostate cancer	2.87e-05	0.000138	CcSEcCtD
Esomeprazole—Fatigue—Capecitabine—prostate cancer	2.87e-05	0.000138	CcSEcCtD
Esomeprazole—Hyperhidrosis—Prednisone—prostate cancer	2.87e-05	0.000137	CcSEcCtD
Esomeprazole—Mental disorder—Epirubicin—prostate cancer	2.86e-05	0.000137	CcSEcCtD
Esomeprazole—Erythema multiforme—Doxorubicin—prostate cancer	2.86e-05	0.000137	CcSEcCtD
Esomeprazole—Pain—Capecitabine—prostate cancer	2.85e-05	0.000136	CcSEcCtD
Esomeprazole—Constipation—Capecitabine—prostate cancer	2.85e-05	0.000136	CcSEcCtD
Esomeprazole—Malnutrition—Epirubicin—prostate cancer	2.84e-05	0.000136	CcSEcCtD
Esomeprazole—Feeling abnormal—Docetaxel—prostate cancer	2.83e-05	0.000136	CcSEcCtD
Esomeprazole—Diarrhoea—Etoposide—prostate cancer	2.83e-05	0.000136	CcSEcCtD
Esomeprazole—Anorexia—Prednisone—prostate cancer	2.83e-05	0.000135	CcSEcCtD
Esomeprazole—Eye disorder—Doxorubicin—prostate cancer	2.82e-05	0.000135	CcSEcCtD
Esomeprazole—Tinnitus—Doxorubicin—prostate cancer	2.82e-05	0.000135	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Docetaxel—prostate cancer	2.81e-05	0.000135	CcSEcCtD
Esomeprazole—Flushing—Doxorubicin—prostate cancer	2.8e-05	0.000134	CcSEcCtD
Esomeprazole—Flatulence—Epirubicin—prostate cancer	2.8e-05	0.000134	CcSEcCtD
Esomeprazole—Tension—Epirubicin—prostate cancer	2.79e-05	0.000134	CcSEcCtD
Esomeprazole—Dysgeusia—Epirubicin—prostate cancer	2.78e-05	0.000133	CcSEcCtD
Esomeprazole—Nervousness—Epirubicin—prostate cancer	2.76e-05	0.000132	CcSEcCtD
Esomeprazole—Back pain—Epirubicin—prostate cancer	2.75e-05	0.000132	CcSEcCtD
Esomeprazole—Feeling abnormal—Capecitabine—prostate cancer	2.74e-05	0.000131	CcSEcCtD
Esomeprazole—Dizziness—Etoposide—prostate cancer	2.74e-05	0.000131	CcSEcCtD
Esomeprazole—Muscle spasms—Epirubicin—prostate cancer	2.73e-05	0.000131	CcSEcCtD
Esomeprazole—Immune system disorder—Doxorubicin—prostate cancer	2.73e-05	0.000131	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Capecitabine—prostate cancer	2.72e-05	0.00013	CcSEcCtD
Esomeprazole—Mediastinal disorder—Doxorubicin—prostate cancer	2.72e-05	0.00013	CcSEcCtD
Esomeprazole—Abdominal pain—Docetaxel—prostate cancer	2.72e-05	0.00013	CcSEcCtD
Esomeprazole—Body temperature increased—Docetaxel—prostate cancer	2.72e-05	0.00013	CcSEcCtD
Esomeprazole—Chills—Doxorubicin—prostate cancer	2.71e-05	0.00013	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Prednisone—prostate cancer	2.7e-05	0.000129	CcSEcCtD
Esomeprazole—Insomnia—Prednisone—prostate cancer	2.68e-05	0.000129	CcSEcCtD
Esomeprazole—Vision blurred—Epirubicin—prostate cancer	2.68e-05	0.000128	CcSEcCtD
Esomeprazole—Alopecia—Doxorubicin—prostate cancer	2.67e-05	0.000128	CcSEcCtD
Esomeprazole—Paraesthesia—Prednisone—prostate cancer	2.66e-05	0.000128	CcSEcCtD
Esomeprazole—Mental disorder—Doxorubicin—prostate cancer	2.65e-05	0.000127	CcSEcCtD
Esomeprazole—Urticaria—Capecitabine—prostate cancer	2.65e-05	0.000127	CcSEcCtD
Esomeprazole—Ill-defined disorder—Epirubicin—prostate cancer	2.64e-05	0.000126	CcSEcCtD
Esomeprazole—Body temperature increased—Capecitabine—prostate cancer	2.63e-05	0.000126	CcSEcCtD
Esomeprazole—Abdominal pain—Capecitabine—prostate cancer	2.63e-05	0.000126	CcSEcCtD
Esomeprazole—Vomiting—Etoposide—prostate cancer	2.63e-05	0.000126	CcSEcCtD
Esomeprazole—Malnutrition—Doxorubicin—prostate cancer	2.63e-05	0.000126	CcSEcCtD
Esomeprazole—Anaemia—Epirubicin—prostate cancer	2.63e-05	0.000126	CcSEcCtD
Esomeprazole—Agitation—Epirubicin—prostate cancer	2.61e-05	0.000125	CcSEcCtD
Esomeprazole—Dyspepsia—Prednisone—prostate cancer	2.61e-05	0.000125	CcSEcCtD
Esomeprazole—Rash—Etoposide—prostate cancer	2.61e-05	0.000125	CcSEcCtD
Esomeprazole—Dermatitis—Etoposide—prostate cancer	2.61e-05	0.000125	CcSEcCtD
Esomeprazole—Headache—Etoposide—prostate cancer	2.59e-05	0.000124	CcSEcCtD
Esomeprazole—Flatulence—Doxorubicin—prostate cancer	2.59e-05	0.000124	CcSEcCtD
Esomeprazole—Tension—Doxorubicin—prostate cancer	2.58e-05	0.000124	CcSEcCtD
Esomeprazole—Decreased appetite—Prednisone—prostate cancer	2.58e-05	0.000124	CcSEcCtD
Esomeprazole—Dysgeusia—Doxorubicin—prostate cancer	2.58e-05	0.000123	CcSEcCtD
Esomeprazole—Malaise—Epirubicin—prostate cancer	2.56e-05	0.000123	CcSEcCtD
Esomeprazole—Fatigue—Prednisone—prostate cancer	2.56e-05	0.000123	CcSEcCtD
Esomeprazole—Nervousness—Doxorubicin—prostate cancer	2.55e-05	0.000122	CcSEcCtD
Esomeprazole—Vertigo—Epirubicin—prostate cancer	2.55e-05	0.000122	CcSEcCtD
Esomeprazole—Leukopenia—Epirubicin—prostate cancer	2.54e-05	0.000122	CcSEcCtD
Esomeprazole—Back pain—Doxorubicin—prostate cancer	2.54e-05	0.000122	CcSEcCtD
Esomeprazole—Constipation—Prednisone—prostate cancer	2.54e-05	0.000122	CcSEcCtD
Esomeprazole—Hypersensitivity—Docetaxel—prostate cancer	2.53e-05	0.000121	CcSEcCtD
Esomeprazole—Muscle spasms—Doxorubicin—prostate cancer	2.53e-05	0.000121	CcSEcCtD
Esomeprazole—Palpitations—Epirubicin—prostate cancer	2.51e-05	0.00012	CcSEcCtD
Esomeprazole—Cough—Epirubicin—prostate cancer	2.48e-05	0.000119	CcSEcCtD
Esomeprazole—Vision blurred—Doxorubicin—prostate cancer	2.48e-05	0.000119	CcSEcCtD
Esomeprazole—Asthenia—Docetaxel—prostate cancer	2.47e-05	0.000118	CcSEcCtD
Esomeprazole—Nausea—Etoposide—prostate cancer	2.46e-05	0.000118	CcSEcCtD
Esomeprazole—Hypertension—Epirubicin—prostate cancer	2.45e-05	0.000118	CcSEcCtD
Esomeprazole—Hypersensitivity—Capecitabine—prostate cancer	2.45e-05	0.000118	CcSEcCtD
Esomeprazole—Feeling abnormal—Prednisone—prostate cancer	2.44e-05	0.000117	CcSEcCtD
Esomeprazole—Ill-defined disorder—Doxorubicin—prostate cancer	2.44e-05	0.000117	CcSEcCtD
Esomeprazole—Pruritus—Docetaxel—prostate cancer	2.43e-05	0.000117	CcSEcCtD
Esomeprazole—Anaemia—Doxorubicin—prostate cancer	2.43e-05	0.000116	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Prednisone—prostate cancer	2.43e-05	0.000116	CcSEcCtD
Esomeprazole—Chest pain—Epirubicin—prostate cancer	2.42e-05	0.000116	CcSEcCtD
Esomeprazole—Myalgia—Epirubicin—prostate cancer	2.42e-05	0.000116	CcSEcCtD
Esomeprazole—Arthralgia—Epirubicin—prostate cancer	2.42e-05	0.000116	CcSEcCtD
Esomeprazole—Agitation—Doxorubicin—prostate cancer	2.42e-05	0.000116	CcSEcCtD
Esomeprazole—Anxiety—Epirubicin—prostate cancer	2.41e-05	0.000116	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.4e-05	0.000115	CcSEcCtD
Esomeprazole—Discomfort—Epirubicin—prostate cancer	2.39e-05	0.000115	CcSEcCtD
Esomeprazole—Asthenia—Capecitabine—prostate cancer	2.39e-05	0.000114	CcSEcCtD
Esomeprazole—Malaise—Doxorubicin—prostate cancer	2.37e-05	0.000114	CcSEcCtD
Esomeprazole—Dry mouth—Epirubicin—prostate cancer	2.37e-05	0.000113	CcSEcCtD
Esomeprazole—Vertigo—Doxorubicin—prostate cancer	2.36e-05	0.000113	CcSEcCtD
Esomeprazole—Urticaria—Prednisone—prostate cancer	2.36e-05	0.000113	CcSEcCtD
Esomeprazole—Pruritus—Capecitabine—prostate cancer	2.36e-05	0.000113	CcSEcCtD
Esomeprazole—Leukopenia—Doxorubicin—prostate cancer	2.35e-05	0.000113	CcSEcCtD
Esomeprazole—Diarrhoea—Docetaxel—prostate cancer	2.35e-05	0.000113	CcSEcCtD
Esomeprazole—Abdominal pain—Prednisone—prostate cancer	2.34e-05	0.000112	CcSEcCtD
Esomeprazole—Body temperature increased—Prednisone—prostate cancer	2.34e-05	0.000112	CcSEcCtD
Esomeprazole—Confusional state—Epirubicin—prostate cancer	2.34e-05	0.000112	CcSEcCtD
Esomeprazole—Palpitations—Doxorubicin—prostate cancer	2.32e-05	0.000111	CcSEcCtD
Esomeprazole—Anaphylactic shock—Epirubicin—prostate cancer	2.32e-05	0.000111	CcSEcCtD
Esomeprazole—Infection—Epirubicin—prostate cancer	2.3e-05	0.00011	CcSEcCtD
Esomeprazole—Cough—Doxorubicin—prostate cancer	2.29e-05	0.00011	CcSEcCtD
Esomeprazole—Shock—Epirubicin—prostate cancer	2.28e-05	0.000109	CcSEcCtD
Esomeprazole—Diarrhoea—Capecitabine—prostate cancer	2.28e-05	0.000109	CcSEcCtD
Esomeprazole—Nervous system disorder—Epirubicin—prostate cancer	2.27e-05	0.000109	CcSEcCtD
Esomeprazole—Dizziness—Docetaxel—prostate cancer	2.27e-05	0.000109	CcSEcCtD
Esomeprazole—Thrombocytopenia—Epirubicin—prostate cancer	2.27e-05	0.000109	CcSEcCtD
Esomeprazole—Hypertension—Doxorubicin—prostate cancer	2.27e-05	0.000109	CcSEcCtD
Esomeprazole—Tachycardia—Epirubicin—prostate cancer	2.26e-05	0.000108	CcSEcCtD
Esomeprazole—Skin disorder—Epirubicin—prostate cancer	2.25e-05	0.000108	CcSEcCtD
Esomeprazole—Hyperhidrosis—Epirubicin—prostate cancer	2.24e-05	0.000107	CcSEcCtD
Esomeprazole—Arthralgia—Doxorubicin—prostate cancer	2.24e-05	0.000107	CcSEcCtD
Esomeprazole—Chest pain—Doxorubicin—prostate cancer	2.24e-05	0.000107	CcSEcCtD
Esomeprazole—Myalgia—Doxorubicin—prostate cancer	2.24e-05	0.000107	CcSEcCtD
Esomeprazole—Anxiety—Doxorubicin—prostate cancer	2.23e-05	0.000107	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.22e-05	0.000107	CcSEcCtD
Esomeprazole—Discomfort—Doxorubicin—prostate cancer	2.21e-05	0.000106	CcSEcCtD
Esomeprazole—Anorexia—Epirubicin—prostate cancer	2.21e-05	0.000106	CcSEcCtD
Esomeprazole—Dizziness—Capecitabine—prostate cancer	2.2e-05	0.000106	CcSEcCtD
Esomeprazole—Dry mouth—Doxorubicin—prostate cancer	2.19e-05	0.000105	CcSEcCtD
Esomeprazole—Vomiting—Docetaxel—prostate cancer	2.19e-05	0.000105	CcSEcCtD
Esomeprazole—Hypersensitivity—Prednisone—prostate cancer	2.19e-05	0.000105	CcSEcCtD
Esomeprazole—Rash—Docetaxel—prostate cancer	2.17e-05	0.000104	CcSEcCtD
Esomeprazole—Dermatitis—Docetaxel—prostate cancer	2.17e-05	0.000104	CcSEcCtD
Esomeprazole—Confusional state—Doxorubicin—prostate cancer	2.16e-05	0.000104	CcSEcCtD
Esomeprazole—Headache—Docetaxel—prostate cancer	2.15e-05	0.000103	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	2.15e-05	0.000501	CbGpPWpGaD
Esomeprazole—Anaphylactic shock—Doxorubicin—prostate cancer	2.15e-05	0.000103	CcSEcCtD
Esomeprazole—Infection—Doxorubicin—prostate cancer	2.13e-05	0.000102	CcSEcCtD
Esomeprazole—Asthenia—Prednisone—prostate cancer	2.13e-05	0.000102	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	2.12e-05	0.000493	CbGpPWpGaD
Esomeprazole—Vomiting—Capecitabine—prostate cancer	2.12e-05	0.000101	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.11e-05	0.000101	CcSEcCtD
Esomeprazole—Shock—Doxorubicin—prostate cancer	2.11e-05	0.000101	CcSEcCtD
Esomeprazole—Nervous system disorder—Doxorubicin—prostate cancer	2.1e-05	0.000101	CcSEcCtD
Esomeprazole—Thrombocytopenia—Doxorubicin—prostate cancer	2.1e-05	0.000101	CcSEcCtD
Esomeprazole—Rash—Capecitabine—prostate cancer	2.1e-05	0.000101	CcSEcCtD
Esomeprazole—Pruritus—Prednisone—prostate cancer	2.1e-05	0.000101	CcSEcCtD
Esomeprazole—Insomnia—Epirubicin—prostate cancer	2.1e-05	0.000101	CcSEcCtD
Esomeprazole—Dermatitis—Capecitabine—prostate cancer	2.1e-05	0.000101	CcSEcCtD
Esomeprazole—Tachycardia—Doxorubicin—prostate cancer	2.09e-05	0.0001	CcSEcCtD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	2.09e-05	0.000487	CbGpPWpGaD
Esomeprazole—Headache—Capecitabine—prostate cancer	2.09e-05	0.0001	CcSEcCtD
Esomeprazole—Skin disorder—Doxorubicin—prostate cancer	2.08e-05	9.99e-05	CcSEcCtD
Esomeprazole—Paraesthesia—Epirubicin—prostate cancer	2.08e-05	9.98e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	2.08e-05	0.000483	CbGpPWpGaD
Esomeprazole—Hyperhidrosis—Doxorubicin—prostate cancer	2.07e-05	9.94e-05	CcSEcCtD
Esomeprazole—Dyspnoea—Epirubicin—prostate cancer	2.07e-05	9.91e-05	CcSEcCtD
Esomeprazole—Somnolence—Epirubicin—prostate cancer	2.06e-05	9.88e-05	CcSEcCtD
Esomeprazole—Anorexia—Doxorubicin—prostate cancer	2.05e-05	9.8e-05	CcSEcCtD
Esomeprazole—Nausea—Docetaxel—prostate cancer	2.04e-05	9.79e-05	CcSEcCtD
Esomeprazole—Dyspepsia—Epirubicin—prostate cancer	2.04e-05	9.79e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—CSAD—prostate cancer	2.04e-05	0.000474	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CBR1—prostate cancer	2.04e-05	0.000474	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TST—prostate cancer	2.04e-05	0.000474	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ADI1—prostate cancer	2.04e-05	0.000474	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PSAT1—prostate cancer	2.04e-05	0.000474	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GRHL1—prostate cancer	2.04e-05	0.000474	CbGpPWpGaD
Esomeprazole—Diarrhoea—Prednisone—prostate cancer	2.03e-05	9.72e-05	CcSEcCtD
Esomeprazole—Decreased appetite—Epirubicin—prostate cancer	2.02e-05	9.66e-05	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	2.01e-05	0.000468	CbGpPWpGaD
Esomeprazole—Gastrointestinal disorder—Epirubicin—prostate cancer	2e-05	9.6e-05	CcSEcCtD
Esomeprazole—Fatigue—Epirubicin—prostate cancer	2e-05	9.58e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	1.99e-05	0.000463	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	1.98e-05	0.000461	CbGpPWpGaD
Esomeprazole—Constipation—Epirubicin—prostate cancer	1.98e-05	9.51e-05	CcSEcCtD
Esomeprazole—Pain—Epirubicin—prostate cancer	1.98e-05	9.51e-05	CcSEcCtD
Esomeprazole—Nausea—Capecitabine—prostate cancer	1.98e-05	9.48e-05	CcSEcCtD
Esomeprazole—Dizziness—Prednisone—prostate cancer	1.96e-05	9.4e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	1.96e-05	0.000455	CbGpPWpGaD
Esomeprazole—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.96e-05	9.37e-05	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—GGT1—prostate cancer	1.95e-05	0.000453	CbGpPWpGaD
Esomeprazole—Insomnia—Doxorubicin—prostate cancer	1.94e-05	9.3e-05	CcSEcCtD
Esomeprazole—Paraesthesia—Doxorubicin—prostate cancer	1.93e-05	9.24e-05	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—NCOA1—prostate cancer	1.92e-05	0.000446	CbGpPWpGaD
Esomeprazole—Dyspnoea—Doxorubicin—prostate cancer	1.91e-05	9.17e-05	CcSEcCtD
Esomeprazole—Feeling abnormal—Epirubicin—prostate cancer	1.91e-05	9.16e-05	CcSEcCtD
Esomeprazole—Somnolence—Doxorubicin—prostate cancer	1.91e-05	9.14e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—UGT2B17—prostate cancer	1.9e-05	0.000441	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—UGT2B15—prostate cancer	1.9e-05	0.000441	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CKMT2—prostate cancer	1.9e-05	0.000441	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GRHPR—prostate cancer	1.9e-05	0.000441	CbGpPWpGaD
Esomeprazole—Gastrointestinal pain—Epirubicin—prostate cancer	1.9e-05	9.09e-05	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	1.89e-05	0.00044	CbGpPWpGaD
Esomeprazole—Dyspepsia—Doxorubicin—prostate cancer	1.89e-05	9.05e-05	CcSEcCtD
Esomeprazole—Vomiting—Prednisone—prostate cancer	1.89e-05	9.04e-05	CcSEcCtD
Esomeprazole—Rash—Prednisone—prostate cancer	1.87e-05	8.96e-05	CcSEcCtD
Esomeprazole—Dermatitis—Prednisone—prostate cancer	1.87e-05	8.95e-05	CcSEcCtD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	1.87e-05	0.000434	CbGpPWpGaD
Esomeprazole—Decreased appetite—Doxorubicin—prostate cancer	1.87e-05	8.94e-05	CcSEcCtD
Esomeprazole—Headache—Prednisone—prostate cancer	1.86e-05	8.9e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	1.85e-05	0.000431	CbGpPWpGaD
Esomeprazole—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.85e-05	8.88e-05	CcSEcCtD
Esomeprazole—Fatigue—Doxorubicin—prostate cancer	1.85e-05	8.87e-05	CcSEcCtD
Esomeprazole—Urticaria—Epirubicin—prostate cancer	1.84e-05	8.83e-05	CcSEcCtD
Esomeprazole—Pain—Doxorubicin—prostate cancer	1.84e-05	8.8e-05	CcSEcCtD
Esomeprazole—Constipation—Doxorubicin—prostate cancer	1.84e-05	8.8e-05	CcSEcCtD
Esomeprazole—Abdominal pain—Epirubicin—prostate cancer	1.83e-05	8.79e-05	CcSEcCtD
Esomeprazole—Body temperature increased—Epirubicin—prostate cancer	1.83e-05	8.79e-05	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—RXRA—prostate cancer	1.83e-05	0.000424	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—MED12—prostate cancer	1.82e-05	0.000424	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MBTPS1—prostate cancer	1.78e-05	0.000414	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AOX1—prostate cancer	1.78e-05	0.000414	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—RFK—prostate cancer	1.78e-05	0.000414	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SULT2B1—prostate cancer	1.78e-05	0.000414	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PGAM2—prostate cancer	1.78e-05	0.000414	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTM3—prostate cancer	1.78e-05	0.000414	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NAGLU—prostate cancer	1.78e-05	0.000414	CbGpPWpGaD
Esomeprazole—Feeling abnormal—Doxorubicin—prostate cancer	1.77e-05	8.48e-05	CcSEcCtD
Esomeprazole—Nausea—Prednisone—prostate cancer	1.76e-05	8.44e-05	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—COMT—prostate cancer	1.76e-05	0.000409	CbGpPWpGaD
Esomeprazole—Gastrointestinal pain—Doxorubicin—prostate cancer	1.76e-05	8.41e-05	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—GSTP1—prostate cancer	1.75e-05	0.000407	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	1.74e-05	0.000405	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	1.73e-05	0.000403	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	1.73e-05	0.000401	CbGpPWpGaD
Esomeprazole—Hypersensitivity—Epirubicin—prostate cancer	1.71e-05	8.19e-05	CcSEcCtD
Esomeprazole—Urticaria—Doxorubicin—prostate cancer	1.71e-05	8.17e-05	CcSEcCtD
Esomeprazole—Body temperature increased—Doxorubicin—prostate cancer	1.7e-05	8.13e-05	CcSEcCtD
Esomeprazole—Abdominal pain—Doxorubicin—prostate cancer	1.7e-05	8.13e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—CYP3A43—prostate cancer	1.69e-05	0.000393	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AMACR—prostate cancer	1.69e-05	0.000393	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—DEGS1—prostate cancer	1.69e-05	0.000393	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NAT1—prostate cancer	1.69e-05	0.000393	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SRD5A2—prostate cancer	1.69e-05	0.000393	CbGpPWpGaD
Esomeprazole—Asthenia—Epirubicin—prostate cancer	1.66e-05	7.98e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.66e-05	0.000386	CbGpPWpGaD
Esomeprazole—Pruritus—Epirubicin—prostate cancer	1.64e-05	7.86e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—HSD17B1—prostate cancer	1.61e-05	0.000375	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.61e-05	0.000375	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GSTM1—prostate cancer	1.61e-05	0.000374	CbGpPWpGaD
Esomeprazole—Diarrhoea—Epirubicin—prostate cancer	1.59e-05	7.61e-05	CcSEcCtD
Esomeprazole—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	1.59e-05	0.000369	CbGpPWpGaD
Esomeprazole—Hypersensitivity—Doxorubicin—prostate cancer	1.58e-05	7.58e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.55e-05	0.00036	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.54e-05	0.000359	CbGpPWpGaD
Esomeprazole—Asthenia—Doxorubicin—prostate cancer	1.54e-05	7.38e-05	CcSEcCtD
Esomeprazole—Dizziness—Epirubicin—prostate cancer	1.53e-05	7.35e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.53e-05	0.000355	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	1.53e-05	0.000354	CbGpPWpGaD
Esomeprazole—Pruritus—Doxorubicin—prostate cancer	1.52e-05	7.28e-05	CcSEcCtD
Esomeprazole—CYP3A4—Metabolism—HAO1—prostate cancer	1.51e-05	0.00035	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	1.5e-05	0.00035	CbGpPWpGaD
Esomeprazole—Vomiting—Epirubicin—prostate cancer	1.47e-05	7.07e-05	CcSEcCtD
Esomeprazole—Diarrhoea—Doxorubicin—prostate cancer	1.47e-05	7.04e-05	CcSEcCtD
Esomeprazole—Rash—Epirubicin—prostate cancer	1.46e-05	7.01e-05	CcSEcCtD
Esomeprazole—Dermatitis—Epirubicin—prostate cancer	1.46e-05	7e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.45e-05	0.000338	CbGpPWpGaD
Esomeprazole—Headache—Epirubicin—prostate cancer	1.45e-05	6.96e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—B4GALT4—prostate cancer	1.44e-05	0.000334	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HPGD—prostate cancer	1.44e-05	0.000334	CbGpPWpGaD
Esomeprazole—Dizziness—Doxorubicin—prostate cancer	1.42e-05	6.8e-05	CcSEcCtD
Esomeprazole—Nausea—Epirubicin—prostate cancer	1.38e-05	6.6e-05	CcSEcCtD
Esomeprazole—Vomiting—Doxorubicin—prostate cancer	1.36e-05	6.54e-05	CcSEcCtD
Esomeprazole—Rash—Doxorubicin—prostate cancer	1.35e-05	6.49e-05	CcSEcCtD
Esomeprazole—Dermatitis—Doxorubicin—prostate cancer	1.35e-05	6.48e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—TNFRSF21—prostate cancer	1.35e-05	0.000314	CbGpPWpGaD
Esomeprazole—Headache—Doxorubicin—prostate cancer	1.34e-05	6.44e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—MTAP—prostate cancer	1.31e-05	0.000306	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP7B1—prostate cancer	1.31e-05	0.000306	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.29e-05	0.000299	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SRD5A1—prostate cancer	1.28e-05	0.000298	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SULT1E1—prostate cancer	1.28e-05	0.000298	CbGpPWpGaD
Esomeprazole—Nausea—Doxorubicin—prostate cancer	1.27e-05	6.11e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.24e-05	0.000289	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TST—prostate cancer	1.23e-05	0.000285	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ADI1—prostate cancer	1.23e-05	0.000285	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CBR1—prostate cancer	1.23e-05	0.000285	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CSAD—prostate cancer	1.23e-05	0.000285	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PSAT1—prostate cancer	1.23e-05	0.000285	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GRHL1—prostate cancer	1.23e-05	0.000285	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.23e-05	0.000285	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HSD17B3—prostate cancer	1.22e-05	0.000284	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ACSL4—prostate cancer	1.22e-05	0.000284	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.21e-05	0.000281	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PHGDH—prostate cancer	1.17e-05	0.000272	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—UMPS—prostate cancer	1.17e-05	0.000272	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ARG2—prostate cancer	1.17e-05	0.000272	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.17e-05	0.000271	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LDHB—prostate cancer	1.15e-05	0.000267	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CKMT2—prostate cancer	1.14e-05	0.000265	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GRHPR—prostate cancer	1.14e-05	0.000265	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.14e-05	0.000265	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.14e-05	0.000265	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP3A5—prostate cancer	1.13e-05	0.000262	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TCN2—prostate cancer	1.09e-05	0.000253	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—UCP3—prostate cancer	1.09e-05	0.000253	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PDHA1—prostate cancer	1.09e-05	0.000253	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTA3—prostate cancer	1.09e-05	0.000253	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.07e-05	0.000249	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NAGLU—prostate cancer	1.07e-05	0.000249	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.07e-05	0.000249	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—RFK—prostate cancer	1.07e-05	0.000249	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTM3—prostate cancer	1.07e-05	0.000249	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PGAM2—prostate cancer	1.07e-05	0.000249	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AOX1—prostate cancer	1.07e-05	0.000249	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HSD3B1—prostate cancer	1.04e-05	0.000242	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC22A3—prostate cancer	1.04e-05	0.000242	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.02e-05	0.000236	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AMACR—prostate cancer	1.02e-05	0.000236	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.02e-05	0.000236	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—DEGS1—prostate cancer	1.02e-05	0.000236	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NAT1—prostate cancer	1.02e-05	0.000236	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.01e-05	0.000234	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TBXAS1—prostate cancer	9.97e-06	0.000232	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTA4—prostate cancer	9.97e-06	0.000232	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	9.74e-06	0.000226	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTA2—prostate cancer	9.71e-06	0.000226	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HSD17B1—prostate cancer	9.7e-06	0.000225	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SULT1A1—prostate cancer	9.59e-06	0.000223	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCG5—prostate cancer	9.59e-06	0.000223	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTA1—prostate cancer	9.37e-06	0.000218	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTO1—prostate cancer	9.26e-06	0.000215	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HSD3B2—prostate cancer	9.26e-06	0.000215	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NAT2—prostate cancer	9.26e-06	0.000215	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	8.91e-06	0.000207	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLCB2—prostate cancer	8.88e-06	0.000206	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LRP2—prostate cancer	8.88e-06	0.000206	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP2C18—prostate cancer	8.88e-06	0.000206	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—P4HB—prostate cancer	8.71e-06	0.000202	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—B4GALT4—prostate cancer	8.65e-06	0.000201	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HPGD—prostate cancer	8.65e-06	0.000201	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC22A1—prostate cancer	8.47e-06	0.000197	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	8.38e-06	0.000195	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SULT2A1—prostate cancer	8.26e-06	0.000192	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TNFRSF21—prostate cancer	8.13e-06	0.000189	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MED12—prostate cancer	8.12e-06	0.000189	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GNG5—prostate cancer	8.06e-06	0.000187	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MTAP—prostate cancer	7.91e-06	0.000184	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP7B1—prostate cancer	7.91e-06	0.000184	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NCOA3—prostate cancer	7.76e-06	0.00018	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.71e-06	0.000179	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.71e-06	0.000179	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	7.63e-06	0.000177	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HPGDS—prostate cancer	7.41e-06	0.000172	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HSD17B3—prostate cancer	7.35e-06	0.000171	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ACSL4—prostate cancer	7.35e-06	0.000171	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ACHE—prostate cancer	7.18e-06	0.000167	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTT1—prostate cancer	7.18e-06	0.000167	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP2A6—prostate cancer	7.1e-06	0.000165	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.07e-06	0.000164	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ARG2—prostate cancer	7.05e-06	0.000164	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PHGDH—prostate cancer	7.05e-06	0.000164	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—UMPS—prostate cancer	7.05e-06	0.000164	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LDHB—prostate cancer	6.91e-06	0.000161	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKR1C3—prostate cancer	6.91e-06	0.000161	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PRKACB—prostate cancer	6.87e-06	0.00016	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP17A1—prostate cancer	6.8e-06	0.000158	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.78e-06	0.000158	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.71e-06	0.000156	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTA3—prostate cancer	6.55e-06	0.000152	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PDHA1—prostate cancer	6.55e-06	0.000152	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TCN2—prostate cancer	6.55e-06	0.000152	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—UCP3—prostate cancer	6.55e-06	0.000152	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NCOA2—prostate cancer	6.48e-06	0.000151	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HSD3B1—prostate cancer	6.25e-06	0.000145	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC22A3—prostate cancer	6.25e-06	0.000145	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC5A5—prostate cancer	6.18e-06	0.000144	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP2E1—prostate cancer	6.04e-06	0.00014	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTA4—prostate cancer	5.99e-06	0.000139	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.99e-06	0.000139	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NQO1—prostate cancer	5.97e-06	0.000139	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TH—prostate cancer	5.88e-06	0.000137	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.85e-06	0.000136	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTA2—prostate cancer	5.84e-06	0.000136	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP3A4—prostate cancer	5.82e-06	0.000135	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.79e-06	0.000135	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.77e-06	0.000134	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCG5—prostate cancer	5.77e-06	0.000134	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP1B1—prostate cancer	5.72e-06	0.000133	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTA1—prostate cancer	5.63e-06	0.000131	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTO1—prostate cancer	5.57e-06	0.000129	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NAT2—prostate cancer	5.57e-06	0.000129	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.57e-06	0.000129	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GGT1—prostate cancer	5.54e-06	0.000129	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NCOA1—prostate cancer	5.46e-06	0.000127	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP19A1—prostate cancer	5.38e-06	0.000125	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLCB2—prostate cancer	5.34e-06	0.000124	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LRP2—prostate cancer	5.34e-06	0.000124	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.34e-06	0.000124	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—P4HB—prostate cancer	5.24e-06	0.000122	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—RXRA—prostate cancer	5.19e-06	0.000121	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC22A1—prostate cancer	5.1e-06	0.000118	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.05e-06	0.000117	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—COMT—prostate cancer	5e-06	0.000116	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTP1—prostate cancer	4.98e-06	0.000116	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.97e-06	0.000115	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ITPR1—prostate cancer	4.9e-06	0.000114	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MED12—prostate cancer	4.88e-06	0.000114	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GNG5—prostate cancer	4.85e-06	0.000113	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.82e-06	0.000112	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NCOA3—prostate cancer	4.67e-06	0.000108	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TYMS—prostate cancer	4.63e-06	0.000108	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTM1—prostate cancer	4.58e-06	0.000106	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LPL—prostate cancer	4.49e-06	0.000104	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HPGDS—prostate cancer	4.45e-06	0.000103	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.43e-06	0.000103	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP1A1—prostate cancer	4.34e-06	0.000101	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTT1—prostate cancer	4.32e-06	0.0001	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ACHE—prostate cancer	4.32e-06	0.0001	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ERCC2—prostate cancer	4.3e-06	0.0001	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.27e-06	9.92e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.15e-06	9.65e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PRKACB—prostate cancer	4.13e-06	9.6e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.09e-06	9.5e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MTHFR—prostate cancer	4.04e-06	9.4e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARA—prostate cancer	3.97e-06	9.22e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NCOA2—prostate cancer	3.9e-06	9.05e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CAV1—prostate cancer	3.73e-06	8.67e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.72e-06	8.64e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.63e-06	8.44e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NQO1—prostate cancer	3.59e-06	8.34e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.56e-06	8.28e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TH—prostate cancer	3.54e-06	8.22e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.44e-06	8e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CG—prostate cancer	3.4e-06	7.9e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GGT1—prostate cancer	3.33e-06	7.75e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NCOA1—prostate cancer	3.28e-06	7.63e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.24e-06	7.52e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—INS—prostate cancer	3.22e-06	7.47e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CREBBP—prostate cancer	3.15e-06	7.32e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—RXRA—prostate cancer	3.12e-06	7.26e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—COMT—prostate cancer	3.01e-06	6.99e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTP1—prostate cancer	2.99e-06	6.96e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.99e-06	6.94e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ITPR1—prostate cancer	2.95e-06	6.85e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NOS3—prostate cancer	2.82e-06	6.55e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TYMS—prostate cancer	2.78e-06	6.47e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTM1—prostate cancer	2.75e-06	6.39e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LPL—prostate cancer	2.7e-06	6.28e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.61e-06	6.06e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.6e-06	6.05e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ERCC2—prostate cancer	2.59e-06	6.01e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTGS2—prostate cancer	2.58e-06	5.99e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MTHFR—prostate cancer	2.43e-06	5.65e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARA—prostate cancer	2.39e-06	5.54e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTEN—prostate cancer	2.25e-06	5.23e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CAV1—prostate cancer	2.24e-06	5.21e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—EP300—prostate cancer	2.15e-06	4.99e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.04e-06	4.75e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—INS—prostate cancer	1.93e-06	4.49e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CREBBP—prostate cancer	1.89e-06	4.4e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.8e-06	4.17e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NOS3—prostate cancer	1.7e-06	3.94e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.59e-06	3.69e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.57e-06	3.64e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTGS2—prostate cancer	1.55e-06	3.6e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTEN—prostate cancer	1.35e-06	3.14e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKT1—prostate cancer	1.3e-06	3.01e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—EP300—prostate cancer	1.29e-06	3e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.54e-07	2.22e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKT1—prostate cancer	7.8e-07	1.81e-05	CbGpPWpGaD
